Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin membrane graft with autologous growth factor eye drops vs amniotic membrane graft in primary pterygium surgery
2025-520640-15-00Phase 4Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of PRGF-Endoret in pterygium (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Primary recurrence rate. Planned start Jan 2025; status: authorised.
02
Drugs
PRGF-Endoret
03
Conditions
pterygium
Beyond the preview
Go deeper on 2025-520640-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520640-15-00.